AssayIndex
ASY cross-section

ASY by compound

ASY records split by compound, with the index-wide comparison for the same compound beside each one. 25 compounds, 190 records. Cells below n=3 print their raw values instead of a median.

25 compounds190 records
CompoundClassReportsASY median %Index median %Δ (pp)SpecPass %
RetatrutideIncretin2698.3698.37-0.0296.5100
TirzepatideIncretin1798.7898.55+0.2397.0100
OxytocinHypothalamic1399.9399.81+0.1298.5100
ExenatideIncretin1299.3398.98+0.3598.0100
BPC-157Tissue-repair1299.6999.16+0.5398.0100
PramlintideIncretin1198.9599.10-0.1597.5100
HexarelinGrowth-hormone1199.8299.59+0.2399.0100
Kisspeptin-10Melanocortin-receptor1199.6699.28+0.3898.5100
TB-500Tissue-repair999.9399.53+0.4098.5100
Enclomiphene citrateNon-peptide999.8899.44+0.4498.5100
PT-141 (Bremelanotide)Melanocortin-receptor999.5799.38+0.1998.5100
LiraglutideIncretin899.9099.00+0.9197.5100
VilonShort899.9399.65+0.2899.0100
Thymosin α1Tissue-repair7 n=799.3799.40-0.0397.5100
GHRP-2Growth-hormone6 n=699.8099.28+0.5299.0100
N-Acetyl Semax AmideNeuroactive5 n=599.8899.35+0.5398.5100
SS-31 (Elamipretide)Metabolic4 n=499.8799.53+0.3498.5100
SelankNeuroactive3 n=399.8399.59+0.2499.0100
PEG-MGFGrowth-hormone2 n=2n<397.7592.0100
Humanin (HNG)Metabolic2 n=2n<399.1297.5100
ARA-290Tissue-repair1 n=1n<399.4298.0100
MOTS-cMetabolic1 n=1n<399.1398.0100
GHRP-6Growth-hormone1 n=1n<399.5499.00
KPVTissue-repair1 n=1n<399.6499.0100
TriptorelinHypothalamic1 n=1n<399.4198.5100
97.497.898.398.899.299.7100.1RetatrutideRetatrutide: Q1 97.98, median 98.36, Q3 98.88, n=26n=26TirzepatideTirzepatide: Q1 98.47, median 98.78, Q3 98.85, n=17outlier 99.49n=17OxytocinOxytocin: Q1 99.65, median 99.93, Q3 99.93, n=13n=13ExenatideExenatide: Q1 99.26, median 99.33, Q3 99.39, n=12outlier 99.61outlier 99.70n=12BPC-157BPC-157: Q1 99.59, median 99.69, Q3 99.88, n=12n=12PramlintidePramlintide: Q1 98.90, median 98.95, Q3 99.22, n=11n=11HexarelinHexarelin: Q1 99.68, median 99.82, Q3 99.91, n=11n=11Kisspeptin-10Kisspeptin-10: Q1 99.39, median 99.66, Q3 99.93, n=11n=11TB-500TB-500: Q1 99.88, median 99.93, Q3 99.93, n=9outlier 99.78n=9Enclomiphene citrateEnclomiphene citrate: Q1 99.80, median 99.88, Q3 99.93, n=9outlier 99.56n=9PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.48, median 99.57, Q3 99.66, n=9outlier 99.09n=9LiraglutideLiraglutide: Q1 99.84, median 99.90, Q3 99.93, n=8outlier 99.59n=8VilonVilon: Q1 99.91, median 99.93, Q3 99.93, n=8outlier 99.65outlier 99.86n=8Thymosin α1Thymosin α1: Q1 99.24, median 99.37, Q3 99.41, n=7outlier 98.93n=7 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines ASY actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. Asymchem Laboratories (Tianjin) Co., Ltd. lists considerably more than the 25 compounds above. Of those 25, 17 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the ASY catalogue at asymchem.org →